We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese's Infringement Complaint Voted to Be Investigated
Read MoreHide Full Article
Celanese Corporation (CE - Free Report) had filed a complaint against the unlawful importation of certain artificial sweeteners into the U.S. with the United States International Trade Commission (USITC) last month. The company had filed this complaint particularly for investigation of the import of Acesulfame Potassium (Ace-K). Celanese said last week that the commission has voted in favor of launching the investigation into the import of the sweeteners.
Celanese had claimed that numerous producers of Ace-K unlawfully imported the sweeteners made using its patented technology from China into the U.S. The manufacturers had been alerted of the infringement by the filing.
The investigation is based on alleged violations of section 337 of the U.S. Tariff Act of 1930, which relates to the importation of high-potency sweeteners into the U.S. The importations allegedly infringe U.S. Patent No. 9,024,016, owned by Celanese. As part of the investigation, the commission will consider a general prohibition order, preventing the import of all infringing sweeteners into the country.
Shares of Celanese closed 1.8% lower at $77.29 on Nov 25.
Celanese kept its earnings streak alive with a beat in third-quarter 2016. Moreover, its adjusted earnings of $1.67 per share increased 11.3% year over year. In the reported quarter, the company entered into a definitive agreement to fully acquire Forli, Italy-based SO.F.TER. Group, one of the largest independent thermoplastics compounders in the world. This acquisition will nearly double the number of Celanese global engineered materials platforms.
The company retained its expectations of 8–10% growth in adjusted earnings per share for 2016, factoring in the benefits of productivity actions and operational excellence as well as strength of commercial models.
Celanese’s strategic measures including productivity and efficiency improvement actions should lend support to its earnings in 2016. Further, it is expected to gain from capacity expansion and growth initiatives in the emerging regions. Moreover, the company continues to generate strong cash flows and remains focused on returning value to its shareholders.
Koppers Holdings has an expected long-term growth of 10%.
Chemours has an expected long-term growth of around 15.5%.
Kronos Worldwide has an expected long-term growth of around 5%.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Celanese's Infringement Complaint Voted to Be Investigated
Celanese Corporation (CE - Free Report) had filed a complaint against the unlawful importation of certain artificial sweeteners into the U.S. with the United States International Trade Commission (USITC) last month. The company had filed this complaint particularly for investigation of the import of Acesulfame Potassium (Ace-K). Celanese said last week that the commission has voted in favor of launching the investigation into the import of the sweeteners.
Celanese had claimed that numerous producers of Ace-K unlawfully imported the sweeteners made using its patented technology from China into the U.S. The manufacturers had been alerted of the infringement by the filing.
The investigation is based on alleged violations of section 337 of the U.S. Tariff Act of 1930, which relates to the importation of high-potency sweeteners into the U.S. The importations allegedly infringe U.S. Patent No. 9,024,016, owned by Celanese. As part of the investigation, the commission will consider a general prohibition order, preventing the import of all infringing sweeteners into the country.
Shares of Celanese closed 1.8% lower at $77.29 on Nov 25.
CELANESE CP-A Price
CELANESE CP-A Price | CELANESE CP-A Quote
Celanese kept its earnings streak alive with a beat in third-quarter 2016. Moreover, its adjusted earnings of $1.67 per share increased 11.3% year over year. In the reported quarter, the company entered into a definitive agreement to fully acquire Forli, Italy-based SO.F.TER. Group, one of the largest independent thermoplastics compounders in the world. This acquisition will nearly double the number of Celanese global engineered materials platforms.
The company retained its expectations of 8–10% growth in adjusted earnings per share for 2016, factoring in the benefits of productivity actions and operational excellence as well as strength of commercial models.
Celanese’s strategic measures including productivity and efficiency improvement actions should lend support to its earnings in 2016. Further, it is expected to gain from capacity expansion and growth initiatives in the emerging regions. Moreover, the company continues to generate strong cash flows and remains focused on returning value to its shareholders.
Celanese currently carries a Zacks Rank #2 (Buy).
Stocks to Consider
Some other well-placed companies in the chemical space include Koppers Holdings Inc. (KOP - Free Report) , The Chemours Company (CC - Free Report) and Kronos Worldwide, Inc. (KRO - Free Report) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Koppers Holdings has an expected long-term growth of 10%.
Chemours has an expected long-term growth of around 15.5%.
Kronos Worldwide has an expected long-term growth of around 5%.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>